Machado-Joseph disease is a neurodegenerative disease without effective treatment. Patients with Machado-Joseph disease exhibit significant motor impairments such as gait ataxia, associated with multiple neuropathological changes including mutant ATXN3 inclusions, marked neuronal loss and atrophy of the cerebellum. Thus, an effective treatment of symptomatic patients with Machado-Joseph disease may require cell replacement, which we investigated in this study. For this purpose, we injected cerebellar neural stem cells into the cerebellum of adult Machado-Joseph disease transgenic mice and assessed the effect on the neuropathology, neuroinflammation mediators and neurotrophic factor levels and motor coordination. We found that upon transplantation into the cerebellum of adult Machado-Joseph disease mice, cerebellar neural stem cells differentiate into neurons, astrocytes and oligodendrocytes. Importantly, cerebellar neural stem cell transplantation mediated a significant and robust alleviation of the motor behaviour impairments, which correlated with preservation from Machado-Joseph disease-associated neuropathology, namely reduction of Purkinje cell loss, reduction of cellular layer shrinkage and mutant ATXN3 aggregates. Additionally, a significant reduction of neuroinflammation and an increase of neurotrophic factors levels was observed, indicating that transplantation of cerebellar neural stem cells also triggers important neuroprotective effects. Thus, cerebellar neural stem cells have the potential to be used as a cell replacement and neuroprotective approach for Machado-Joseph disease therapy.
Introduction
Machado-Joseph disease, also known as spinocerebellar ataxia type 3 (SCA3), is a progressive neurodegenerative disease caused by a mutation involving the over-repetition of the CAG trinucleotide in the ATXN3 gene (Kawaguchi et al., 1994) . This mutation is translated into a large polyglutamine tract within the ATXN3 protein, which-when over 55 glutamine repetitions-becomes toxic (Maciel et al., 2001; Paulson, 2007) causing neuronal dysfunction and degeneration in specific brain regions leading to motor and non-motor symptoms (Coutinho and Andrade, 1978; Paulson, 2007; Pedroso et al., 2013) . The neuropathology in patients with Machado-Joseph disease is severe and widespread. In vivo brain MRI evidenced significant atrophy of the caudate nucleus, putamen, cerebellum, medial cerebellar peduncle and brainstem Rub et al., 2013) . Additionally, post-mortem pathoanatomical studies revealed widespread neuronal loss in the cerebral cortex, basal ganglia, thalamus, midbrain, pons, medulla oblongata and cerebellum (Scherzed et al., 2012; Seidel et al., 2012) . Namely, neuronal loss at the cerebellar Purkinje cell layer and deep nuclei was observed (Scherzed et al., 2012) . Moreover, patients' brains exhibit protein aggregates in neurons of both affected and unaffected brain areas (Paulson et al., 1997; Bichelmeier et al., 2007; Seidel et al., 2012) .
There is no effective therapy for this disorder but promising results have been observed upon gene silencing, autophagy activation or proteolysis inhibition (NascimentoFerreira et al., 2011 (NascimentoFerreira et al., , 2013 Simoes et al., 2012; Nobrega et al., 2013) . Nevertheless, at the time of intervention, symptomatic patients may exhibit extensive neurodegeneration, particularly within the cerebellum, and may therefore demand a cell replacement approach.
Neural stem cells (NSCs) are self-renewing, multipotent cells with the ability to differentiate into the neural cells (neurons, astrocytes and oligodendrocytes) that constitute the nervous system (Taupin, 2006) . The transplantation of NSCs has been successfully used as a cell replacement strategy in several animal models of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and spinocerebellar ataxia type 1 (Wernig et al., 2008; Blurton-Jones et al., 2009; Chintawar et al., 2009) . Moreover, recent clinical trials have provided evidence of donor cell engraftment and demonstrated that cell transplantation is safe (Gupta et al., 2012; Guzman et al., 2013) .
The positive modulation on neurological disorders mediated by the transplantation of NSCs is triggered not only by the capacity to integrate new neural cells into the host tissue, contributing to the replacement of damaged cells, but also by several bystander capacities, such as the production of neurotrophic factors and modulation of neuroinflammation (Pluchino et al., 2005; Blurton-Jones et al., 2009; Cossetti et al., 2012; Giusto et al., 2014) .
The levels of neurotrophic factors, proteins that control the survival, development and function of neurons, can be increased by NSC transplantation (Blurton-Jones et al., 2009) . Moreover, it has been demonstrated that there is cross-talk between the transplanted NSCs and the host environment (Cossetti et al., 2012) , that allows a more adequate control over the production of these trophic factors. Additionally, it has been reported that the transplantation of NSCs can also enhance endogenous host neurogenesis (Mine et al., 2013) and the host environment can in turn influence NSC graft survival and differentiation (Reekmans et al., 2012) . Thus, NSCs could provide a means to efficiently deliver neurotrophic factors and enhance host neurogenesis, thereby increasing neuronal survival and originating new neurons.
Neuroinflammation is among the mechanisms that determine cell degeneration in neurodegenerative disorders (Khansari and Sperlagh, 2012) . Transplanted NSCs exert control over the endogenous inflammatory mediators stimulating neuroprotection through anti-inflammatory and anti-apoptotic mechanisms (Pluchino et al., 2009; Morales et al., 2010; Drago et al., 2013) . Accordingly, a significant reduction of mRNA levels of proinflammatory mediators, such as IL1B and TNFA, which increased neuronal survival in the diseased brains, has been reported to occur upon NSC transplantation (Cossetti et al., 2012) .
In the present study we investigated, for the first time, whether NSC transplantation would alleviate the phenotype of a severe early-onset transgenic mouse model of Machado-Joseph disease that we and others have used in previous studies (Torashima et al., 2008; NascimentoFerreira et al., 2013; Nobrega et al., 2013) . We observed that cerebellar NSC transplantation led to significant improvement of the Machado-Joseph disease-associated neuropathology, increase of BDNF levels, reduction of neuroinflammation and robust and significant improvement of the motor impairments.
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C with 5% CO 2 . After 7 days in culture, neurospheres were collected by centrifugation and plated in poly-D-lysine coated coverslips. To obtain differentiated cultures, the plated neurospheres were allowed to differentiate for 7 days, as previously described (Hester et al., 2009) . Briefly, to differentiate NSCs into neurons, basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF) were removed from the culture medium and all-trans retinoic acid (Sigma) at 2 mM and forskolin (Sigma) at 5 mM were added. To induce differentiation into astrocytes, NSCs were cultured in Dulbecco's modified Eagle medium (DMEM)-F12/ GlutaMAX TM supplemented with 2% B27 and 10% foetal bovine serum. Oligodendrocyte differentiation was induced by culturing the cells in DMEM-F12/GlutaMAX TM , 2% B27 and insulin-like growth factor 1 (Sigma) at 200 ng/ml. NSCs were allowed to differentiate for 7-14 days.
Immunocytochemistry of neuron, astrocyte and oligodendrocyte cultures obtained after differentiation Neurospheres were embedded into optimal cutting temperature compound (O.C.T.) and sliced into 10-mm sections on a cryostat (Leica) and collected to SuperFrost Õ Plus glass slides (Thermo Scientific). Neurospheres and differentiated cultures were fixed with 4% paraformaldehyde (Sigma) and permeabilized with 1% Triton TM X-100 (Sigma) followed by 1 h blocking with 3% bovine serum albumin (BSA) (Sigma) and overnight incubation with the primary antibodies at 4 C. The following primary antibodies diluted in 3% BSA were used: mouse anti-b3 tubulin (1:500, Invitrogen), rabbit anti-GFAP (1:400, Dako), rabbit anti-NG2 (1:150, Millipore) and mouse anti-SOX2 (1:200, R&D Systems). Subsequently, the incubation with the secondary antibodies was performed for 2 h at room temperature. The secondary antibodies diluted in 1% BSA used were: goat anti-mouse Alexa Fluor Õ 594 and goat anti-rabbit Alexa Fluor Õ 488 (1:200, Invitrogen). Nuclei were stained with 4, 6-diamidino-2-phenylindoline, DAPI (1:5000, Applichem). For the oligodendrocyte marker O4 assessment, the mouse anti-oligodendrocyte marker O4 antibody (Chemicon, 20 mg/ml) was used according to the manufacturer's instructions. Fluorescence images were acquired with a Zeiss Axiovert 200 imaging microscope.
Evaluation of differentiation into mature functional neurons by single cell calcium imaging
The capacity of NSCs to give rise to functional neurons was assessed in the cultures differentiated into neurons using single cell calcium imaging. The intracellular calcium concentrations of single cells on 50 mM KCl depolarization, which is considered a marker of functional differentiated neurons, and on 100 mM histamine depolarization, which is a marker of undifferentiated neural progenitors cells, were assessed as previously described (Agasse et al., 2008; Sousa-Ferreira et al., 2011) . Briefly, cells were incubated with 5 mM Fura-2AM and 0.02% pluronic acid F-127 (both from Molecular Probes) for 60 min at 37 C, in Krebs buffer (pH 7.4) with 0.1% BSA. The coverslips were mounted on an RC-20 chamber in a PH3 platform (Warner Instruments) and the chamber was filled with Krebs buffer. The intracellular calcium concentration [Ca2 + ]i (basal) was measured for 4 min. Then, a depolarization with 50 mM KCl/Krebs, over 2 min, followed by a 4-min repolarization period and a depolarization with 100 mM histamine/Krebs, over 2 min, followed by 4 min of repolarization was performed. During the experiment, cells were alternately excited at 340 and 380 nm, and a ratio of fluorescence intensity for these wavelengths was obtained (F340/F380). The fluorescence was recorded by an AxioCam digital camera coupled to an Axiovert 200 fluorescence microscope (Zeiss) and the image analysis was performed with the Metafluor 2 software (Zeiss). The [Ca2 + ]i changes were analysed from the cell bodies that were identified as neurons (cells responding to potassium) or neuroprogenitors (cells responding to histamine) cells. A potassium response was considered for KCl/basal ratio of 1.15, corresponding to a 15% increase in [Ca2 + ]i and a histamine response for a histamine/potassium ratio 51. Three coverslips (one microscopic field per coverslip) from independent cell preparations in a total of $100 cells/coverslip were analysed.
NSC infection with lentivirus encoding for GFP
The lentiviral vectors encoding for green fluorescent protein (GFP, SIN-PGK-GFP-WHV) were produced in 293T cells using a four-plasmid system as described previously (de Almeida et al., 2001; Alves et al., 2008) . NSCs with one-two passages were transduced with lentiviral vectors encoding GFP. Briefly, neurospheres were collected by centrifugation, washed with phosphate-buffered saline (PBS) and incubated with StemPro Õ Accutase Õ (Gibco) for 5 min. Cells were washed in PBS and 150 000 cells/500 ml supplemented culture medium were plated in 12 MW plates. Then lentiviral vectors encoding GFP (the equivalent to 100 ng of p24 antigen) were added to cells $2 h after plating. Twenty-four hours later 500 ml of culture medium was added and on the second day the lentiviral vectors were removed by collecting the cells by centrifugation and resuspending them in fresh culture medium. Seven days after starting the transduction the NSCs were assessed for GFP expression with widefield fluorescence microscopy on a Zeiss Axiovert 200 imaging microscope. The percentage of NSCs transduced and the relative fluorescence units (RFU) were assessed by flow cytometry. Briefly, cells were collected in microfuge tubes, washed with cold PBS, dissociated from neurospheres to single cells with StemPro Õ Accutase Õ (Gibco), washed with cold PBS, fixed with 1% paraformaldehyde, washed again with cold PBS, filtered through a 70-mm cell strainer, to obtain single-cell suspensions, and resuspended in 500 ml of cold PBS. Samples were immediately analysed in a FACSCalibur TM flow cytometer (BD, Biosciences). Data were then analysed by Cell Quest software (BD).
In vivo experiments Animals
Machado-Joseph disease transgenic mice (C57BL/6 background) expressing the N-terminal-truncated human ATXN3, with 69 glutamine repeats and an N-terminal haemagglutinin (HA) epitope, driven specifically in cerebellar Purkinje cells by the L7 promoter (Torashima et al., 2008) and wild-type mice were used. The experiments were carried out in accordance with the European Community Council directive (86/609/ EEC) for the care and use of laboratory animals.
Stereotaxic injection of NSC
The animals (postnatal days 42-46) received a single injection of 100 000 NSCs [100 000 cells/2 ml Hank's Balanced Salt Solution (HBSS)] injected at 0.25 ml/min at the coordinates: À 1.6 mm rostral to lambda, 0 mm midline, and 1 mm ventral to the skull surface, with the mouth bar set at À 3.3.
Behavioural tests
To evaluate the impact of NSC transplantation on the motor phenotype, seven Machado-Joseph disease mice were injected with NSCs, six were injected with HBSS (control) and four wild-type animals (littermate of the used Machado-Joseph disease mice) were used. Mice were trained on a battery of motor tests, starting at 42-46 days of age, and performed these every 1-2 weeks until 8 weeks post-injection. They were assessed by an experienced operator in a blind-fashion manner. All tests were performed in the same dark room after 30 min of acclimatization. Mice performed four trials for each test and time point, with a 15-min rest between trials.
Rotarod
Motor coordination and balance were evaluated with a Rotarod apparatus (Letica Scientific Instruments). Mice were placed on the Rotarod at a constant speed (5 rpm) for a maximum of 5 min and, at accelerated speed (4-40 rpm in 5 min), and the latency to fall was recorded. For analysis, the mean latency to fall off the Rotarod of three trials was used.
Footprint pattern analysis
The footprint pattern test was used to compare the gait of Machado-Joseph disease mice injected with NSCs with mice injected with HBSS-Hind-and fore-feet were coated with black and white non-toxic paints, and the animals walked along a 100-cm long, 10-cm wide runway (with 15-cm high walls) over a sheet of green paper. The footprint patterns were analysed for the distance from left front footprint/hind footprint overlap to measure uniformity of step alternation. The distance between the centre of the hind footprint and the centre of the preceding front footprint was recorded over a sequence of five consecutive steps, excluding footprints made at the beginning and end of the run.
Beam-walking test
In the beam-walking test (also known as the raised-beam or raised-bridge test) mice were trained to cross an elevated beam to reach an enclosed escape platform ( Supplementary Fig. 1A) . A round beam with a 9-mm diameter was raised to a height of 21 cm and the mice walked 40 cm to reach the escape platform. The latency to cross the beam (up to 60 s) and the motor coordination applied during the test was recorded. Animal performance was then evaluated and scored according to a predefined rating scale ( Supplementary Fig. 1B ).
Tissue preparation
After an overdose of pentobarbital, mice were intracardiacally perfused with PBS followed by fixation with 4% cold paraformaldehyde. The brains were removed and post-fixed in 4% paraformaldehyde for 24 h at 4 C and cryoprotected by incubation in 25% sucrose/PBS for 48 h at 4 C. Then, brains were frozen at À 80 C and 30 mm sagittal sections were cut using a cryostat (LEICA CM3050 S). Slices throughout the entire cerebellum were collected and stored in 48-well plates as free-floating sections in PBS/0.05 mM sodium azide. The slices were stored at 4 C until processing.
Immunohistochemistry
Immunohistochemical procedure was initiated with 1 h of blocking and permeabilization in 0.3% Triton TM X-100 and 10% normal goat serum/PBS at room temperature. Sections were incubated overnight at 4 C with the following primary antibodies prepared in 2% normal goat serum and 0.05% Triton TM X-100/PBS: mouse anti-b3 tubulin (1:500, Invitrogen), rabbit anti-GFAP (1:400, Dako), rabbit anti-NG2 (1:200, Millipore), mouse anti-SOX2 (1:200, R&D Systems), rabbit anti-calbindin (1:1000, Millipore), mouse anti-HA (1:1000, InvivoGen), and rabbit anti-cleaved caspase 3 (1:600, Cell Signaling). Sections were washed twice with PBS and incubated in secondary antibody, prepared in 2% normal goat serum, goat-anti rabbit or mouse conjugated to Alexa Fluor Õ 488 or 594 (1:200, Invitrogen) for 2 h at room temperature. Nuclei staining was performed with DAPI, sections were washed three times with PBS and then mounted on gelatinized slides. After being dried, slides were mounted in Mowiol Õ reagent (Sigma). Widefield fluorescence images were acquired with a Â 20 and Â 40 objective on a Zeiss Axiovert 200 imaging microscope. Confocal fluorescence images were obtained with a Â 40 objective ( Â 2 crop) on a LSM Zeiss microscope. Three dimensional reconstructions were obtained from confocal z-stacks with the ImageJ software.
TUNEL assay
Cerebellar sections were stained using the in situ cell death detection kit, TMR Red (Roche), following the supplier's instructions, to investigate apoptotic cell death. A negative (no enzyme solution used) and a positive control [cerebellar sections were incubated with DNase (Qiagen) before cell death detection] were performed. Widefield fluorescence images were acquired with a Â20 objective on a Zeiss Axiovert 200 imaging microscope. Confocal fluorescence images were obtained with a Â 40 objective on a LSM Zeiss microscope. Three dimensional reconstructions were obtained from confocal zstacks with the ImageJ software.
Quantification of Purkinje cells and mutant ATXN3 aggregates
Quantitative analysis of calbindin-positive cells (Purkinje cells) and haemagglutinin aggregates (aggregates with mutant ATXN3) was performed by scanning the four sections immediately before the first section in which the NSC were detected (in NSC-injected mice), and in the HBSS-injected and noninjected transgenic mice the sections with the same localization on the 48-well plate as the sections used for the NSC-injected mice were used. For assessment of calbindin-positive cells, whole cerebellum of the selected sections was scanned with a Zeiss PALM Axiovert 200M microscope. Whereas the evaluation of the HA-tagged aggregates was only performed at the lobule where the NSCs were injected [lobule (L) 5] and on a lobule far from the injection site (L9, control lobule), both Lobule 5 and 9 were scanned with Zeiss PALM Axiovert 200M microscope. For quantification the ImageJ acquisition and analysis software (NIH, USA) was used.
Cresyl violet staining
Sections were pre-mounted on gelatinized slides, dried overnight at room temperature and stained with Cresyl violet for 2 min, differentiated in acetate buffer pH 3.8 to 4 (2.72% sodium acetate and 1.2% acetic acid; 1:4 v/v), dehydrated by passing twice through ethanol and toluol solutions, and mounted with Eukitt Õ (O. Kindler).
Quantification of granular and molecular layers size
Quantification was made over four sections per animal and for each section, four fields in each lobule, in fixed regions, were acquired with a Zeiss Axiovert 200 imaging microscope. For each acquired field, two measurements were made blindly in the same region for all animals, and results converted to micrometres using ImageJ software (NIH, USA).
Quantitative real time PCR
Machado-Joseph disease mice (postnatal Days 42-46) received a single injection of 100 000 cerebellar NSCs at the cerebellar vermis, as previously described. Four weeks after transplantation, mice were sacrificed by cervical dislocation and a punch ($10 mg) of the cerebellum was immediately frozen at À 80 C. Frozen cerebellar punches were slightly thawed at room temperature and RNA extraction was performed with QIAzol Õ lysis reagent and RNeasy Õ Mini Kit (Qiagen). Briefly, the RNA at the aqueous phase obtained with the QIAzol Õ lysis reagent was cleaned up with the RNeasy Õ Mini Kit using DNase digestion at the RNeasy Õ spin column, according to the manufacturer's recommendations. The RNA concentration and purity were determined with NanoDrop TM 2000 (Thermo Scientific).
cDNA synthesis was performed with iScript TM cDNA Synthesis Kit (Bio-Rad) from 1 mg of total RNA according to the manufacturer's instructions. PCR was performed in real time quantitative PCR with the SsoAdvanced TM SYBR Õ Green Supermix Kit (Bio-Rad). The primers used for target and housekeeping genes were the following:
, glutamate receptor, ionotropic, AMPA3 (alpha 3) (Gria3) (QT00167685), gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 (Gabrb2) (QT00172109), vascular endothelial growth factor C (Vegf) (QT00104027), Hprt (QT00166768), all pre-designed (QuantiTect Primer Assays, Qiagen) and human mutant ATXN3 (mut ATXN-3):
0 . Briefly, 2.5 ml of the cDNA obtained in the reverse transcription reaction diluted 10-fold (for Bdnf, Gdnf, Ngf, Gria3, Gabrb2 quantification) or 4-fold (for the remaining genes) with DNase free deionized water were used. The quantitative PCR was performed as follows: one single cycle at 95 C for 30 s, followed by 45 cycles of two steps: first step of 5 s at 95 C, second step of 15 s at 55 C (for Vegf, Gabrb2, Gria3 and mutant ATXN3) or at 61 C (for the remaining genes). The melting curve protocol started immediately after the quantitative PCR and consisted of 5 s heating at 65 C with a 0.5 C temperature increase in each step until 95 C was reached. The threshold cycle (Ct) values were generated automatically by the StepOne TM Software (Applied Biosystems). To each gene, and in each experiment, a standard curve was performed and quantitative PCR efficiency was determined by the software. The mRNA relative quantification with respect to control samples was determined by the Pfaffl method, taking into consideration the different amplification efficiencies of all genes in all experiments.
Statistical analysis
Statistical analysis was performed using Student's t-test or ANOVA for multiple comparisons. Values of P 5 0.05 were considered statistically significant.
Results

Cerebellar NSCs are multipotent and originate functional neurons
Several parameters were assessed to investigate whether cerebellar NSCs, obtained from whole cerebellum, were multipotent cells and had potential to be used in cell replacement-based therapeutic strategies, aiming at neural repair. Cerebellar NSCs were maintained at an undifferentiated proliferative state growing as floating neurospheres, and, as expected, were positive for the multipotent neural stem cell marker SOX2 ( Fig. 1A; upper panel illustrates cells labelled with SOX2 and lower panel SOX2 merged with DAPI). On exposure to three different differentiation protocols (neuronal, oligodendrocyte and astrocyte differentiation), aiming to control the type of neural cells obtained, a mixed culture (Fig.  1B) , composed of astrocytes (Fig. 1C) , oligodendrocytes ( Fig. 1D and E) and neurons (Fig. 1F) , originated from cerebellar NSCs. Moreover, we observed from single cell calcium imaging that 32.59 AE 8.01% of the cells obtained after 7 days of differentiation responded to potassium but not to histamine stimulation, a marker of functional differentiated neurons (Agasse et al., 2008) . However, 51.24 AE 8.57% of the cells depolarized with histamine (Fig. 1G) , a marker of undifferentiated neural progenitors (Agasse et al., 2008) . Thus, cerebellar NSCs are able to give rise to functional mature neurons upon differentiation.
Subventricular zone NSCs are the more common source for NSC transplantation, therefore, we compared the potency of both cerebellar and subventricular zone NSCs. No significant difference was observed concerning the ability to give rise to neural cells upon differentiation (Supplementary Fig. 2A-F) , or at the ability to be the origin of mature functional neurons ( Supplementary  Fig. 2G ). Thus, both cerebellar and subventricular zone NSCs were assessed for in vivo cell replacement potential. 
Survival and differentiation of cerebellar NSCs after transplantation
To identify grafted cerebellar NSCs in the cerebellum of Machado-Joseph disease transgenic mice upon stereotaxic injection, these cells were transduced with lentiviral vectors encoding for GFP (Fig. 2A) . Optimal infection conditions were obtained by transducing cerebellar NSCs with lentivirus (100 ng of p24) under the form of single cells. For these conditions 57.14 AE 4.17% of transduced cells with 721.0 AE 155.53% RFU increase were obtained (Fig. 2B  and C) .
To assess which source of cells, cerebellar or subventricular zone NSCs, would promote a more effective transplant engraftment, both cell types were injected into the cerebellum and striatum of Machado-Joseph disease and wild-type mice, and the survival was assessed at 2 and 4 weeks after the transplantation. As the analysis of the mice tissues allowed detection of cerebellar NSCs in all experiments performed, but not of subventricular zone NSCs, we chose to use cerebellar NSCs for the following experiments (data not shown).
Therefore, cerebellar NSCs expressing GFP were injected into the cerebellum of Machado-Joseph disease mice. We observed that cerebellar NSCs engrafted in the tissue and survived up to 8 weeks after transplantation, the longest time evaluated (Fig. 2D-J) . Minor apoptosis was found at 8 weeks post-transplantation ( Supplementary  Fig. 3 ).
An effective cell replacement-based strategy relies on the ability of the transplanted cerebellar NSCs to differentiate into the three types of neural cells (neurons, astrocytes and oligodendrocytes) (Gaspard and Vanderhaeghen, 2011) . Thus, 8 weeks after the transplantation of cerebellar NSCs expressing GFP into the cerebellum of Machado-Joseph disease mice, sections of the mice brains were analysed for the ability of cerebellar NSCs to differentiate into neural cells by assessing the immunoreactivity of the grafted cells expressing GFP for markers of multipotent (SOX2), and differentiated states: GFAP (astrocytes), NG2 (oligodendrocytes), b3tubulin (neurons) and calbindin (Purkinje cells). Upon transplantation into the cerebellum, while some cells remained positive for SOX2 with the typical round shape of undifferentiated NSCs (Fig. 3A-E and Supplementary Fig. 4A ), other cells differentiated, becoming negative for SOX2 and acquiring a differentiated neural cell-type shape. Co-localization between GFP and markers for neurons (Fig. 3F-H and Supplementary Fig. 4B ), astrocytes (Fig. 3I-K and Supplementary Fig. 4C ) and oligodendrocytes (Fig. 3L-N and Supplementary Fig. 4D ) was observed, indicating that the three types of neural cells originate from cerebellar NSCs. No calbindin-positive cells originated from cerebellar NSCs, indicating that during the study, cerebellar NSCs were not capable of giving rise to new Purkinje cells (Fig. 3O-Q) , similar to what has been observed in in vitro experiments ( Supplementary Fig. 5A-C) .
Robust alleviation of motor impairments
To assess the potential of cerebellar NSC transplantation to promote functional recovery in Machado-Joseph disease, cerebellar NSCs were injected into the cerebellum of Machado-Joseph disease mice and, the motor performance was evaluated and compared to the performance of control HBSS-injected Machado-Joseph disease and wild-type mice. The motor tests (Rotarod, beam-walking and foot print pattern) were carried out every 1 to 2 weeks, until 8 weeks after the cerebellar NSC transplantation.
The Rotarod test, performed at constant speed (Fig. 4A ) at the time of the cerebellar NSC injection into the MachadoJoseph disease mice (5-6 weeks old), already revealed marked motor impairments as compared to the wild-type mice. Throughout the time course of the study mice injected with cerebellar NSCs consistently exhibited better performance as compared to mice injected with HBSS. These differences were significant and robust from 2 weeks after the transplantation at constant Rotarod speed ( Fig. 4A ; NSC 79.39 AE 12.04 s versus HBSS 29.89 AE 4.67 s) and from 4 weeks at accelerated Rotarod speed ( Fig. 4B ; NSC 59.56 AE 2.41 s versus HBSS 30.22 AE 7.46) and were maintained until the end of the study.
This improvement in motor function of mice injected with cerebellar NSCs was further investigated by analysis of the footprint patterns. From 4 weeks post-injection, mice grafted with cerebellar NSCs showed a robust and significantly smaller (better) left overlap than mice injected with HBSS ( Fig. 4C ; NSC 0.761 AE 0.71 cm versus HBSS 1.22 AE 0.13 cm) and, the overlap of the Machado-Joseph disease mice injected with cerebellar NSCs became similar to the overlap of wild-type mice ( Fig. 4C ; NSC 0.761 AE 0.71 cm versus wild-type mice 0.61 AE 0.10 cm). Another quantitative parameter used to confirm the improvement of the motor performance of cerebellar NSC-injected mice was the beam-walking test. Although no significant difference was observed between the performance of cerebellar NSC-injected mice and HBSS-injected mice in this test, there is a clear tendency suggesting that the transplantation of cerebellar NSCs led to an improvement of performance in Machado-Joseph disease mice. Overall, these results indicate that cerebellar NSC transplantation robustly alleviates motor impairments of this Machado-Joseph disease transgenic mouse model.
Cerebellar NSC transplantation reduces Machado-Joseph disease-associated neuropathology
The impact of cerebellar NSC transplantation in MachadoJoseph disease-associated neuropathology was evaluated 8 weeks after the transplantation of cerebellar NSCs into the cerebellum of Machado-Joseph disease mice. Thus, sections of the brain were analysed for the preservation of cellular layer thickness within the cerebellar cortex, number of Purkinje cells and mutant ATXN3 aggregates. Purkinje cells are key elements regulating the cerebellar function and are significantly affected in patients with Machado-Joseph disease (Munoz et al., 2002; Scherzed et al., 2012) and in the transgenic mouse model used in this study. Therefore, we analysed whether the transplantation of cerebellar NSCs would prevent loss of Purkinje cells. Control mice (HBSS-injected) exhibited a significantly reduced number of calbindin-positive Purkinje cells (Fig. 5A ), compared to mice injected with cerebellar NSCs (Fig. 5B) , whose Purkinje cell number was 1.602 AE 0.088 times higher (Fig. 5C) . Additionally, no significant differences were observed between HBSS-injected and non-injected transgenic mice regarding calbindin-positive Purkinje cell numbers (data not shown).
Cerebellar atrophy is another important neuropathological hallmark observed in the mouse model used in this study (Torashima et al., 2008) . Cresyl violet staining revealed that the thickness of the cellular layers was reduced for HBSS-injected mice (Fig. 5D ) as compared to the mice injected with cerebellar NSCs (Fig. 5E) . Moreover, it was observed that the cerebellar NSC transplantation alleviated the cerebellar granular layer atrophy, mainly at the injection site, the Lobule 5 (Fig. 5F , NSC L5 granular layer 128.47 AE 9.51 mm versus HBSS L5 granular layer 85.74 AE 10.51 mm), whereas in a control lobe (L9, far from the injection site) no significant prevention of the atrophy of either the molecular or granular layers was observed.
Neuronal intranuclear inclusions enriched in aggregated mutant ATXN3 are a hallmark of Machado-Joseph disease and are present in Purkinje cells of the cerebellar cortex of the transgenic mice used in this study (Torashima et al., 2008) . Thus, we investigated if the cerebellar NSC transplantation would reduce the number of mutant ATXN3 inclusions. Through quantitative real time PCR we observed no significant difference of the mutant ATXN3 mRNA levels of NSC-injected mice versus HBSS-injected mice 4 weeks after the injection (Supplementary Fig. 6 ). However, we observed a reduced number of mutant ATXN3 (HA-tag) inclusions in mice injected with cerebellar NSCs (Fig. 5H ) as compared to HBSS-injected control Motor coordination was assessed in Machado-Joseph disease transgenic mice transplanted with cerebellar NSCs, Machado-Joseph disease transgenic mice injected with HBSS, and in wild-type mice, by (A) Rotarod performance at constant velocity, (B) Rotarod performance at accelerated velocity, (C) foot print overlap, and (D) beam-walking performance over 8 weeks. A significant and robust improvement of the motor phenotype in the cerebellar NSC-transplanted mice, compared to the HBSS-transplanted was observed. Data are presented as mean AE SEM. Two-way ANOVA analysis with Bonferroni post-test ***P 5 0.001,**P 5 0.01 and *P 5 0.05. NSC-transplanted mice (n = 7); HBSS-injected mice (n = 6); wild-type mice (n = 4). mice (Fig. 5G) , suggesting that cerebellar NSC transplantation triggered clearance of mutant ATXN3 inclusions near the injection site [ Fig. 5I ; NSC L5 51% decrease (from 1 to 0.49 AE 0.12)], even though in the control L9 the decrease in the number of aggregates failed to reach significance (Fig. 5I, NSC L9) . No significant differences were observed between HBSS-injected and non-injected transgenic mice for mutant ATXN3 inclusion numbers (data not shown).
Overall, cerebellar NSC transplantation promoted clearance of ATXN3 inclusions and preservation of cerebellar architecture, including Purkinje cells.
Effects of cerebellar NSC transplantation in neurotrophic factors, inflammatory modulators and neurotransmitter receptors levels
Positive modulation on neurological disorders mediated by the transplantation of NSCs is triggered not only by the replacement of damaged and lost cells, but also by bystander capacities, such as the production of neurotrophic factors and modulation of neuroinflammation (Pluchino et al., 2005; Blurton-Jones et al., 2009; Cossetti et al., 2012; Giusto et al., 2014) . Thus, the mRNA levels of a panel of neurotrophic factors, inflammatory modulators and neurotransmitter receptors were assessed by quantitative real time PCR in cerebellar homogenates 4 weeks after cerebellar NSC grafting. Bdnf levels were found to be 4.18 AE 0.99 times higher in cerebellar NSC-transplanted mice (BDNF NSC) compared to HBSS-injected mice (BDNF HBSS) (Fig. 6A) , whereas no significant differences were observed for Gdnf and Ngf levels. Additional controls, wild-type animals and non-injected transgenic mice, were tested for Bdnf and Ngf mRNA levels ( Supplementary  Fig. 7A ). No significant difference was observed for Bdnf levels between non-injected (Bdnf Tg) and HBSS-injected (BDNF Tg HBSS) transgenic mice. Moreover, the Bdnf levels of cerebellar NSC transplanted mice (BDNF Tg NSC) were significantly increased compared to wild-type mice. No significant modification was observed for Ngf levels in all tested mouse groups. Vascular endothelial growth factor (VEGF) is secreted by neural progenitors cells (Mosher et al., 2012) exerting a positive modulation through neurotrophic and neuroprotective effects (Sondell et al., 1999 (Sondell et al., , 2000 . However, we observed no significant modification at the Vegf mRNA levels upon cerebellar NSC transplantation (VEGF NSC) (Fig. 6A) .
Regarding inflammatory modulators, a significant decrease of 32% (from 1 to 0.68 AE 0.05) in the Il1b levels of cerebellar NSC-transplanted mice (IL1B NSC) was observed (Fig. 6B ) as well as a tendency for decrease of the proinflammatory modulators Il6 and Tnfa levels. The control wild-type mice and non-injected transgenic mice were also tested for Il1b and Il6 mRNA levels ( Supplementary Fig. 7B ). As expected, the levels of Il1b and Il6 of non-injected (IL1B Tg and IL6 Tg, respectively) and HBSS-injected (IL1B Tg HBSS and IL6 Tg HBSS, respectively) transgenic mice were increased compared to wild-type mice. Moreover, the Il1b levels of cerebellar NSC-transplanted mice were significantly decreased compared to both non-injected and HBSS-injected transgenic mice. Surprisingly, a significant decrease in the Il1b levels of HBSS-injected mice compared to non-injected transgenic mice was observed. Moreover, the tendency for decrease in Il6 levels of cerebellar NSC transplanted mice (IL6 Tg NSC) was statistically significant when compared to non-injected mice (IL6 Tg). Overall, these results suggest that transplantation of cerebellar NSCs reduces inflammatory mediators in the cerebellum.
A significant upregulation of genes involved in both excitatory and inhibitory neurotransmission-encoding subunits of the ionotropic glutamate receptors 2 and 3 and GABA A receptor b2 were detected after NSC transplantation in a Niemann-Pick disease type C (NP-C) mouse model (Lee et al., 2010) . Thus, to evaluate the impact of cerebellar NSC transplantation into the cerebellar neuronal neurotransmission of Machado-Joseph disease mice, mRNA levels of glutamate receptor 3 (Gria3, previously known as GluR3) and GABA A receptor b2 (Gabrb2) were assessed 4 weeks after the transplantation, by quantitative real-time PCR (Fig. 6C) . A significant increase of In the proinflammatory mediators evaluated Tnfa, Il1b and Il6, a significant decrease was observed in the Il1b levels of the mice injected with cerebellar NSCs (Il1b NSC). (C) GABA A receptor subunit beta 2 (Gabrb2) and glutamate receptor 3 (Gria3) were also evaluated and a significant increase in Gria3 after cerebellar NSC transplantation was detected. NSC-transplanted mice (NSC, n = 11) and HBSS-injected mice (HBSS, n = 8). The quantification was performed with the Paffl method and using Hprt as housekeeping gene. Data are presented as mean AE SEM. ***P 5 0.001 and *P 5 0.05; unpaired Student's t-test.
1.26 AE 0.06 times on the excitatory Gria3 levels was detected for mice transplanted with cerebellar NSCs (GluR3 NSC), which became indistinguishable from wild-type animals ( Supplementary Fig. 7C ), whereas no significant modification on the Gabrb2 levels were detected. This could indicate that cerebellar NSC transplantation modulates the cerebellar neuronal network, not only by preservation of Purkinje cells, as previously described (Fig. 5C ), but also by increasing Gria3 mRNA levels. The quantification of Gria3 and Gabrb2 mRNA in wild-type mice and non-injected transgenic mice revealed that these receptors transcripts are decreased in transgenic mice. Moreover, no significant difference was observed between the non-injected and HBSS-injected mice for these neuronal receptor mRNA levels ( Supplementary Fig. 7C ).
Discussion
Machado-Joseph disease is a polyglutamine neurodegenerative disease and the most common dominantly-inherited cerebellar ataxia, for which there is no effective treatment. Despite promising results of disease modifiers (NascimentoFerreira et al., 2011 (NascimentoFerreira et al., , 2013 Simoes et al., 2012; Nobrega et al., 2013) , in symptomatic patients extensive neuronal loss suggests that cell replacement might be indicated. Here, we show for the first time that transplantation of cerebellar NSCs alleviates motor behaviour deficits and neuropathology in a severely impaired transgenic Machado-Joseph disease mouse model, therefore suggesting a possible therapy for symptomatic cases of this disease.
Adult NSCs and neural precursors cells exist in two main brain regions, the subventricular zone and the subgranular zone of the dentate gyrus in the hippocampus (GonzalezPerez et al., 2012; Ramasamy et al., 2013) . The classic source used to obtain NSCs for neurotransplantation is the subventricular zone. However, there are other available sources of NSCs, such as the cerebellum (Lee et al., 2005) and, as NSCs give rise to progeny in accordance with their region of origin (Klein et al., 2005) , we explored the potential of transplantation of cerebellar NSCs into the cerebellum of Machado-Joseph disease mice as a cell replacement and neuroprotective-based therapy.
Our in vitro results demonstrate that cerebellar NSCs are multipotent and upon differentiation, the three types of neural cells, astrocytes, oligodendrocytes and neurons, as described by others (Lee et al., 2005) , originate from them. Moreover, mature functional neurons were obtained after 7 days of differentiation. Therefore, cerebellar NSCs have the potential to be used in cell replacement-based therapies, the approach that we investigated in this study.
On transplantation into the cerebellum of MachadoJoseph disease mice, cerebellar NSCs survived and differentiated into astrocytes, oligodendrocytes and neurons. However, not all cerebellar NSCs gave rise to differentiated cells, as a pool of SOX2-positive cells remained in the graft in a multipotent state. This is in accordance with previous observations that following transplantation, a fraction of the cells remains in the state of undifferentiated cells (Cao et al., 2002; Cossetti et al., 2012) . This pool of cells might contribute to the transplantation success, through the production of chemical factors such as neurotrophic factors, that promote the differentiation and survival of the graftderived neural cells, as well as to long-lasting beneficial effects over pathological processes (Lu et al., 2003; Carletti et al., 2011) .
Purkinje cells are key effectors of the cerebellum and are compromised in patients with Machado-Joseph disease and the mouse model used in this study. As NSCs give rise to progeny in accordance with their region of origin and, as Purkinje cells are obtained from neural progenitors cells present in the cerebellar ventricular zone (Hoshino, 2006; Hibi and Shimizu, 2012) , we investigated whether NSCs isolated from the cerebellum would differentiate into Purkinje cells. However, we failed to obtain new Purkinje cells both in vitro and in vivo, in accordance with a previous report (Li et al., 2006) . In fact, Purkinje cells are particular and sensitive neurons that interact and cooperate with other cerebellar cells and molecular effectors to regulate cerebellar neuronal circuits (Buffo and Rossi, 2013; White and Sillitoe, 2013) including its own differentiation, migration and integration into the neuronal circuit. Therefore, we speculate that the cerebellum of a 6-week-old mouse may not provide the necessary stimulus for the differentiation of Purkinje cells, which may require additional stimulus and a period of more than 8 weeks. Moreover, Purkinje cell markers are temporally dynamic and their patterns can be different at each cell stage (White and Sillitoe, 2013) , therefore being difficult to predict which markers should be used at each time point after cerebellar NSC transplantation.
The cerebellum has an important role in motor coordination. Lesion of the cerebellum triggers several motor coordination deficits such as gait ataxia. The transgenic mice used in this study exhibit mutant ATXN3 inclusions, marked atrophy of the cerebellum and, at the age of 6 weeks, already exhibit pronounced motor behaviour impairments (Torashima et al., 2008) . The behavioural test results of this study demonstrate, for the first time, that the cerebellar transplantation of cerebellar NSCs triggers a robust and significant alleviation of the motor impairments. Moreover, these therapeutic effects mediated by cerebellar NSCs were associated with a significant and robust reduction of the Machado-Joseph disease-associated neuropathology. Accordingly, Machado-Joseph disease mice transplanted with cerebellar NSCs showed preservation of the number of Purkinje cells, as well as a reduction on the atrophy of the cerebellar cellular layers and reduction of the number of mutant ATXN3 inclusions. As we have not observed differentiation of the cerebellar NSCs into Purkinje cells, but the mice transplanted with cerebellar NSCs still had more Purkinje cells, we conclude that the increased performance in the motor behavioural tests was also mediated by a marked neuroprotective effect triggered by significant changes in the neuronal microenvironment more than resulting from cell replacement.
In fact, an effective cell replacement strategy requires an effective integration of NSC-derived neurons into the neuronal network to establish physiologically relevant connections in the complex brain circuitry (Gaspard and Vanderhaeghen, 2011) . Given the complexity of this cell replacement approach, it is unlikely that the meaningful functional benefits observed after cerebellar NSC transplantation are mainly triggered through an effective cell replacement (Drago et al., 2013) . In fact, it has been suggested that NSC transplantation may generate beneficial effects by reducing neuroinflammation (Pluchino et al., 2009; Drago et al., 2013) and increasing the levels of neurotrophic factors (Blurton-Jones et al., 2009; Xia et al., 2013) . The loss of trophic factors is well documented for several neurodegenerative diseases (Wang et al., 2012) , as well as the neuroprotection promoted by the rescue of trophic factors such as BDNF (Gharami et al., 2008; Blurton-Jones et al., 2009 ). Our results demonstrate that cerebellar NSC transplantation into the cerebellum of Machado-Joseph disease mice significantly increases the Bdnf mRNA levels, indicating that this is one of the mechanisms by which the therapeutic effect observed at the motor phenotype occurs.
The other possible mechanism may be a positive modulation at neuroinflammation, given that a significant reduction of the proinflammatory cytokine Il1b mRNA levels was observed. This is in accordance with previous reports indicating a significant reduction of mRNA levels of Il1b after NSC transplantation, leading to increased neuronal survival (Cossetti et al., 2012) . The unexpected observed lower Il1b levels of HBSS-injected transgenic mice, compared to non-injected transgenic mice, suggest that the activation of the immune system per se (through the stereotaxic surgery), in a scenario of neuroinflammation, might also contribute to the observed reduction in the Il1b levels upon cerebellar NSC transplantation. Thus, our data suggest that the increase in Bdnf levels and reduction of neuroinflammation illustrated by the Il1b decrease, promoted neuroprotection, which resulted in reduced neuronal death and consequently explains the observed enhancement of Purkinje cells numbers and cellular layer thickness. Therefore, cerebellar NSC transplantation improves the neuronal network in the cerebellum of adult Machado-Joseph disease mice. Moreover, it has been reported that overexpression of proinflammatory mediators may trigger signalling cascades in neurons resulting in self-aggregation of proteins and formation of neurotoxic oligomeric species (Morales et al., 2010) . Thus, we hypothesize that the observed reduction in mutant ATXN3 aggregates is a result of the reduction in proinflammatory mediator levels.
In summary, this work demonstrates, for the first time, that upon transplantation into the cerebellum of adult Machado-Joseph disease mice, cerebellar NSCs differentiate into neurons, astrocytes and oligodendrocytes. Moreover, some of the cerebellar NSCs remain undifferentiated, probably contributing to the neuroprotective effects observed by the significant reduction of neuroinflammation and the increase of trophic factors. Given that there is cross-talk between the graft and the host environment (Cossetti et al., 2012) , cerebellar NSCs may survey the host microenvironment providing means to efficiently rescue neurotrophic factor levels and to reduce neuroinflammation, in this way increasing neuronal survival. These molecular and cellular modifications, in turn, trigger a robust and significant alleviation of the motor impairments in Machado-Joseph disease transgenic mice. Therefore, the transplantation of cerebellar NSCs is a promising therapeutic approach that could be brought to patients with Machado-Joseph disease.
